To further reveal one or both transcription factors involved in CCL2 transactivation, JSH-23 and Stattic, inhibitors of NF-κB and STAT3, were administered to PIP5Iγ-overexpressing CRC cells or high PIP5Iγ expression CRC cells. The gene discussed is CCL2; the disease is colorectal carcinoma.